Women's Cancers in Europe : Innovation, Equity and Emerging Needs
About the Event
As part of the European Parliament's Gender Equality Week, the event will focus on the still unmet needs of women living with cancer, the quality of life throughout the entire care pathway, and the value of research and innovation in reducing inequalities in access to treatment.
The discussion will bring together representatives of European and national institutions, including the European Medicines Agency (EMA) and the Italian Medicines Agency (AIFA), leading oncologists and researchers, and representatives of the pharmaceutical industry.
Speakers will include Rossana Berardi, President-elect of the Italian Association of Medical Oncology (AIOM), and Giuseppe Curigliano, President-elect of the European Society for Medical Oncology (ESMO). The event will also feature the testimony of Bianca Balti, founder of Mind Your Cancer ETS.
Hosted by

ECR Bureau
Committees
Delegations
Speakers

Armando Magrelli heads the International Relations Office at the Italian Medicines Agency (AIFA).
His office coordinates the agency's international engagement with the European Medicines Agency, EU institutions and other regulators. He previously served on EMA's Committee for Orphan Medicinal Products and teaches European pharmaceutical legislation at the University of Rome Tor Vergata.
Francesco Pignatti is Scientific Adviser for Oncology at the European Medicines Agency (EMA).
His work focuses on cancer medicine regulation, benefit-risk assessment and patient-preference research. He joined EMA in 1999, following research at the European Organisation for Research and Treatment of Cancer in Brussels, and previously headed EMA's oncology and haematology office.

Bianca BALTI
Founder
Mind Your Cancer ETS
Bianca Balti is the founder of Mind Your Cancer ETS, a foundation established in Milan in 2026 to support people affected by cancer and their caregivers.
An Italian fashion model, she established the organisation following her own experience of cancer. Its stated activities include psychological and emotional support, education and awareness.

Member of the European Parliament
Committees
Delegations

Member of the European Parliament
Committees
Delegations

Member of the European Parliament
Committees
Delegations
Rossana Berardi is President-elect of AIOM and Professor of Medical Oncology at Marche Polytechnic University, where she directs the School of Specialisation in Medical Oncology.
She also leads the oncology clinic at the Marche University Hospital. Her work includes precision oncology, and in 2026 she joined national working groups on molecular tumour boards and oncology medicine assessment.
Giuseppe Curigliano is President-elect of the European Society for Medical Oncology (ESMO) for 2027–2028, Deputy Scientific Director and Director of New Drug Development at the European Institute of Oncology in Milan.
He is also a Professor of Medical Oncology at the University of Milan. His research focuses on early drug development and breast cancer.
Valentina Guarneri is President of Women for Oncology Italy and Director of Oncology Unit 2 at the Veneto Oncology Institute.
She is also Professor of Medical Oncology at the University of Padua and heads its specialist training programme. Her clinical and research work includes breast, lung and ovarian cancers, with a focus on clinical and translational oncology.
Silvia Novello is Full Professor of Medical Oncology at the University of Turin and heads the Thoracic Oncology Unit at San Luigi Gonzaga University Hospital.
She also directs the university's specialist training programme in medical oncology. Her clinical and academic work focuses on thoracic cancers, including lung cancer, and training in oncology.
Giulia Veronesi is Professor of Thoracic Surgery at Vita-Salute San Raffaele University and Director of Thoracic Surgery at IRCCS San Raffaele Hospital in Milan.
She is a member of the steering body of Fondazione Umberto Veronesi. Her work includes lung-cancer screening, thoracic oncology and robotic surgery, following earlier appointments at the European Institute of Oncology and Humanitas.
Alessandra Dorigo is Vice President and Head of Oncology at AstraZeneca Italy, where she leads the company's oncology business.
She joined AstraZeneca in 2023 after two decades at Novartis and related businesses, working across oncology, rare diseases and neuroscience. Her previous position was General Manager for Advanced Accelerator Applications in the UK, Ireland, Nordic and Baltic markets.
Fausto Galanti is Chapter Head of Market Access, Tenders, Public and Regulatory Affairs at Bayer Italy.
His responsibilities span access to medicines, public policy and engagement with health-sector institutions. His professional background includes patient access and government affairs, and he has also taught healthcare-related institutional relations and market regulation at LUMSA University.
Marco Rago is Medical Head Oncology at Novartis Italy.
He works on medical and scientific activities in oncology and haematology, including initiatives addressing the experience and quality of life of people living with chronic myeloid leukaemia. In 2026, he discussed Novartis Italy's VITA LMC Tracker project, designed to support conversations between patients and clinicians.
Gilda Ascione is Medical Director and Head of Medical Affairs Oncology at Daiichi Sankyo Italy.
Her work includes medical affairs in oncology and the development of initiatives addressing the needs of people living with metastatic cancer. She has discussed the company's MetaLAB programme, which brings stakeholders together to identify patient needs and develop possible responses.
Programme
Important – This event is by invitation, and only registered participants will be admitted. Due to capacity constraints, all attendees must register, including those already holding a European Parliament access badge. Registration is mandatory for admission.
European Parliament
60, rue Wiertz 1047 BRUSSEL
Afbeeldingen galerij1



